Card Tech Minutes 2013.01.09

From IHE Wiki
Revision as of 02:54, 10 January 2013 by AntjeSchroeder (talk | contribs) (Created page with "== Attendees == * Alan Katz - ACC * Antje Schroeder - Siemens * Barry Brown - Mortara * Chris Melo - Philips * Paul Dow - ACC * Paul Seifert - Agfa * Paul Varghese - Agfa * Tom...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Attendees

  • Alan Katz - ACC
  • Antje Schroeder - Siemens
  • Barry Brown - Mortara
  • Chris Melo - Philips
  • Paul Dow - ACC
  • Paul Seifert - Agfa
  • Paul Varghese - Agfa
  • Tom Dolan - Philips

Meeting Notes

  1. How important is multiple-vendor Interoperability to you in cardiology workflow

a. critical – it’s one of the top 5 selection criteria and is a deal-breaker b. high – it’s very important and always comes up, but not a buy/not-buy dealbreaker c. medium - it always there and considered d. low – it never really comes up 2. what are key interoperability pain points that you experience today - please specify a. b. c. 3. What is your role in Cardiology IT purchasing decisions a. Decision maker, member of decision making unit b. Decision influencer – consulted by decision makers c. None 4. How important is multiple-vendor Interoperability to you in cardiology IT purchasing decisions a. critical – it’s one of the top 5 selection criteria and is a deal-breaker b. high – it’s very important and always comes up, but not a buy/not-buy dealbreaker c. medium - it always there and considered d. low – it never really comes up 5. Are you aware of IHE (Integrating the Healthcare Enterprise) a.  ? never heard of it b. Somewhat familiar c. Very familiar – continually use it in my discussion on cardiology Interoperability 6. If yes - describe its role in addressing your interoperability concerns a. Very Valuable – please mention specific profiles used b. Not Available – vendors do not have requested profiles or only incomplete support

                                                              i.      Please illustrate 

c. Not fully applicable - it has gaps which doesn’t address my key concerns – please specify 7. Would you like a follow-up to find out more information? a. Contact method ( phone/email) b. no